Letter: Hepatitis B and MAFLD - a consilience of risk factors for hepatocellular carcinoma

被引：2
|
作者：
Zheng, Kenneth I. [1 ]
Zheng, Ming-Hua [1 ,2 ,3 ]
机构：
[1] Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatol, NAFLD Res Ctr, Wenzhou, Peoples R China
[2] Wenzhou Med Univ, Inst Hepatol, Wenzhou, Peoples R China
[3] Key Lab Diag & Treatment Dev Chron Liver Dis Zhej, Wenzhou, Peoples R China
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2021年 / 54卷 / 05期
基金：
中国国家自然科学基金;
关键词：
CIRRHOSIS;
D O I：
10.1111/apt.16532
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LINKED CONTENT This article is linked to Estes et al paper. To view this article, visit
引用
收藏
页码：736 / 737
页数：2
相关论文
共 50 条
  • [31] Reply to: "Risk factors of hepatocellular carcinoma after hepatitis B surface antigen seroclearance"
    Yip, Terry Cheuk-Fung
    Chan, Henry Lik-Yuen
    Wong, Vincent Wai-Sun
    Wong, Grace Lai-Hung
    JOURNAL OF HEPATOLOGY, 2018, 68 (01) : 208 - 209
  • [32] Hepatitis B virus infection and the risk of hepatocellular carcinoma
    Tan, Ya-Jun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (44) : 4853 - 4857
  • [33] Hepatitis B e antigen and the risk of hepatocellular carcinoma
    Yang, HI
    Lu, SN
    Liaw, YF
    You, SL
    Sun, CA
    Wang, UY
    Hsiao, CK
    Chen, PJ
    Chen, DS
    Chen, CJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (03): : 168 - 174
  • [34] Aspirin Use and Risk of Hepatocellular Carcinoma in Hepatitis B
    Fox, Rena K.
    Taddei, Tamar H.
    Kaplan, David E.
    JAMA INTERNAL MEDICINE, 2019, 179 (05) : 640 - 641
  • [35] Hepatitis B virus infection and the risk of hepatocellular carcinoma
    Ya-Jun Tan
    World Journal of Gastroenterology, 2011, 17 (44) : 4853 - 4857
  • [36] HEPATOCELLULAR CARCINOMA RISK IN HISPANICS WITH CHRONIC HEPATITIS B
    Lee, Ariel
    Chung, Phillip
    Jung, Jung
    Wong, Christopher
    Zhou, Kali
    HEPATOLOGY, 2024, 80
  • [37] Risk scores for hepatocellular carcinoma in chronic hepatitis B
    Sherman, Morris
    Kim, Ray W.
    Dziura, James
    HEPATOLOGY, 2015, 61 (06) : 1784 - 1786
  • [38] Hepatitis B e antigen and the risk of hepatocellular carcinoma
    Geier, A
    Gartung, C
    Dietrich, CG
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (21): : 1721 - 1721
  • [39] Comment on "Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients"
    Zhao, Gang
    Shi, Xiaobao
    Zhang, Lingyun
    Liang, Hongyuan
    INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (07) : 1324 - 1325
  • [40] Letter: moderate levels of serum hepatitis B virus DNA alone are not associated with increased risk of hepatocellular carcinoma in chronic hepatitis B patients
    Kumar, Karan
    Mishra, Manjul
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (03) : 575 - 576
12345